This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thompson, E. J. Articles by Bowden, G. T. Search for Related Content PubMed PubMed Citation Articles by Thompson, E. J. Articles by Bowden, G. T.

A Dominant Negative c-jun Specifically Blocks Okadaic Acid-induced Skin Tumor Promotion¹

Department of Pharmacology and Toxicology, The University of Arizona, Tucson, Arizona 85724 [E. J. T., G. T. B.]; Department of Radiation Oncology, Arizona Cancer Center, The University of Arizona, Tucson, Arizona 85724 [J. M., G. T. B.]; and Basic Research Laboratory, National Cancer Institute, Frederick, Maryland 21702 [M. R. Y., N. C.]

Okadaic acid (OA) is a prototypical non-phorbol ester skin tumor-promoting agent that works by inhibiting protein phosphatases, leading to an increase in protein phosphorylation. Increased protein phosphorylation can lead to stimulated signaling through various signal transduction pathways. One or more of the pathways affected by OA leads to increased signaling via the activator protein 1 (AP-1) transcription factor. Because AP-1 signaling has been shown to be required for skin tumor promotion by phorbol ester, studies were undertaken to determine whether AP-1 signaling is also required for 7,12-dimethylbenz(a)anthracene (DMBA)-initiated/OA-promoted skin tumorigenesis. Transgenic mice expressing a dominant negative c-jun (TAM-67) controlled by the keratin 14 promoter in ICR mice were used to determine the effects of OA on AP-1 signaling. By crossing the TAM-67 mice with mice expressing an AP-1-responsive luciferase, it was shown that TAM-67 decreases AP-1 activation in response to OA treatment by 95%. After 7,12-dimethylbenz(a)anthracene initiation, the TAM-67 mice and nontransgenic littermates were promoted with twice weekly applications of OA. These experiments showed that TAM-67 expression decreased tumor multiplicity by 90%. Additional experiments with TAM-67 mice showed that the hyperplastic response to OA is not impaired in these mice, nor were there differences in OA-induced transcription of various genes known to be AP-1 responsive under other conditions. This result suggests that only a subset of AP-1-regulated genes is targeted by TAM-67 when it prevents tumor promotion by OA. A determination of the mechanism by which TAM-67 can block tumor promotion without affecting hyperplasia will be important.

This article has been cited by other articles:

				C. Ma, J. Wang, Y. Gao, T.-W. Gao, G. Chen, K. A. Bower, M. Odetallah, M. Ding, Z. Ke, and J. Luo The Role of Glycogen Synthase Kinase 3{beta} in the Transformation of Epidermal Cells Cancer Res., August 15, 2007; 67(16): 7756 - 7764. [Abstract] [Full Text] [PDF]

				J. Y. Zhang, A. E. Adams, T. W. Ridky, S. Tao, and P. A. Khavari Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human Neoplasia Cancer Res., April 15, 2007; 67(8): 3827 - 3834. [Abstract] [Full Text] [PDF]

				D. Ikebe, B. Wang, H. Suzuki, and M. Kato Suppression of keratinocyte stratification by a dominant negative JunB mutant without blocking cell proliferation. Genes Cells, February 1, 2007; 12(2): 197 - 207. [Abstract] [Full Text] [PDF]

				M. J. Gerdes, M. Myakishev, N. A. Frost, V. Rishi, J. Moitra, A. Acharya, M. R. Levy, S.-w. Park, A. Glick, S. H. Yuspa, et al. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res., August 1, 2006; 66(15): 7578 - 7588. [Abstract] [Full Text] [PDF]

				A. P. Jansen, C. E. Camalier, and N. H. Colburn Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis Cancer Res., July 15, 2005; 65(14): 6034 - 6041. [Abstract] [Full Text] [PDF]

				J. Y. Zhang, S. Tao, R. Kimmel, and P. A. Khavari CDK4 regulation by TNFR1 and JNK is required for NF-{kappa}B-mediated epidermal growth control J. Cell Biol., February 14, 2005; 168(4): 561 - 566. [Abstract] [Full Text] [PDF]

				M. A. Bachelor, S. J. Cooper, E. T. Sikorski, and G. T. Bowden Inhibition of p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Decreases UVB-Induced Activator Protein-1 and Cyclooxygenase-2 in a SKH-1 Hairless Mouse Model Mol. Cancer Res., February 1, 2005; 3(2): 90 - 99. [Abstract] [Full Text] [PDF]

				S. J. Cooper, J. MacGowan, J. Ranger-Moore, M. R. Young, N. H. Colburn, and G. T. Bowden Expression of Dominant Negative c-jun Inhibits Ultraviolet B-Induced Squamous Cell Carcinoma Number and Size in an SKH-1 Hairless Mouse Model Mol. Cancer Res., September 1, 2003; 1(11): 848 - 854. [Abstract] [Full Text] [PDF]